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Thesynthesisandcharacterizationofthesilver(I)chloridecomplexofformula {[AgCI(CMBZT)(TPTP)2]·(MeOH)}(1)(CMBZT
= 5-chloro-2-mercaptobenzothiazole, TPTP = tris(p-tolyl)phosphine) is described. Also the structure of the hydrate derivative
{[AgCI(TPTP)3]·(0.5·H2O)}(2)ofthecorrespondingknownanhydroussilvercomplex(Zartilasetal.,2009),andthepolymorph
3 of the known [AgI(TPTP)3] complex (Zartilas et al., 2009) were determined and compared with the known ones. In addition,
the structure of the known one silver(I) cluster {[AgI(TPTP)]4} (4) (Meijboom et al., 2009) was re-determined at 120(2) K
and possible Ag-Ag interactions were analyzed. The compounds 1–4 were characterized by X-ray crystallography at r.t (1)a n d
120 K (2–4). All these complexes and {[(Et3NH)
+]2 · [Ag6(μ3-Hmna)4(μ3-mna)2]
2− · (DMSO)2 · (H2O)} (5)( H m n a= 2-
mercaptonicotinic acid) were evaluated for cytotoxic and anti-inﬂammatory activity. The in vitro testing of cytotoxic activity
of 1–5 against leiomyosarcoma cancer cells (LMS), were evaluated with Trypan Blue and Thiazolyl Blue Tetrazolium Bromide or
3-(4.5-dimethylthiazol-2-yl)-2.5-diphenyltetrazoliumbromide(MTT)assays.Theﬂowcytometryassayforcomplex1andshowed
that at 15μMo f1, 62.38% of LMS cells undergo apoptosis, while 7% of LMS cells undergo cell necrosis. The antitumor activity of
3 is comparable with that of its reported polymorph (Zartilas et al., 2009). The anti-inﬂammatory, activity of complexes 1–3 and
5 was also studied. The activity towards cell viability was 2 > 3 > 5 > 1 > 4, while the order of the inhibitory activity in cell growth
proliferation follows the order, 2 > 3 > 1 > 4 > 5. The anti-inﬂammatory activity on the other hand is 1 > 2 > 5 > ···> 3.
1.Introduction
Silver(I) complexes with sulfur containing ligands exhibit a
wide range of applications in medicine, in analytical chem-
istry and in the polymer industry [1–5]. The biomedical
applications and uses of silver(I) complexes are related to
their antibacterial action [6, 7] which appears to involve
interaction with DNA [8]. Silver sulphadiazine is a topical
anti-infective, used worldwide for dermal injuries, approved
by the US Food and Drug Administration [9]. It has a broad
antibacterial spectrum including virtually all microbial
species likely to infect the burn wound [9]. Recently, Ag(I)
complexes have also been studied for their antitumor activity
[10–12]. The results showed that [AgBr(TPTP)3]c o m p l e x
possessed the strongest activity against leukemia (L1210),
human T-lymphocyte (Molt4/C8 and CEM) and LMS cells
[12]. The exact mechanism of the anti-tumor action of Ag(I)
compounds is still unknown. It is well known, however, that
manydrugswhichinhibitthegrowthoftumorcellsacteither
by interfering with DNA bases and/or nucleotides or with
the metalloenzymes that are necessary for the rapid growth
of malignant cells [13, 14]. Thus, the molecular design
and structural characterization of silver(I) complexes is an
intriguing aspect of bioinorganic chemistry and metal-based2 Bioinorganic Chemistry and Applications
drugs research [15, 16]. The ability of silver(I) complexes to
adopt geometries with variable nuclearities and structural
diversity also makes the study of silver(I) chemistry very
attractive [3–5, 17]. This self-assembly process between
metal ions and ligands is known to depend on steric and
interactive information stored in the ligand and is governed
by the metal ions through the demands of their coordination
geometry [18, 19]. Recently, a new type of aromaticity, due
to a cyclical delocalization of d as well as (d-p) π-type
orbital electron density instead of the usual p orbitals on
metal-ligand rings, has been reported [20–29], which may
introduce greater stability to the higher-order structures.
This paper, reports the synthesis of the new mixed ligand
silver(I) chloride complex with the heterocyclic thioamide 5-
chloro-2-mercaptobenzothiazole(CMBZT,C7H4ClNS2)and
tri(p-tolyl)phosphine (TPTP, C21H21P) (Scheme 1)o ff o r -
mula {[AgCl(CMBZT)(TPTP)2]·(MeOH)} (1). The hydrate
{[AgCl(TPTP)3]· (0.5·H2O)} (2) of the known anhydrous
silver complex [10]a n dap o l y m o r p h ,3, of the known
[AgI(TPTP)3]c o m p l e x[ 10, 30] were also isolated. The
crystal structure of 4 {[AgI(TPTP)]4} has been previously
reported at 100(2)K [31] but we have extended our
studies here in the determination of its quasiaromaticity,
which results in strong Ag–Ag interactions and thus greater
stability, using data collected at 120K. Complexes 1–4
and the known silver(I) cluster {[{[(Et3NH)+]2·[Ag6(μ3-
Hmna)4(μ3-mna)2]2−·(DMSO)2·(H2O)} (5)( H 2MNA = 2-
mercaptonicotinic acid, C6H5NO2S) [32]w e r et e s t e df o r
their in vitro cytostatic activity against leiomyosarcoma
cancer cells from Wistar rats. Finally, the anti-inﬂammatory
activity of complexes 1–3 and 5 were also evaluated and the
results correlated with those of their anti-tumor activity.
2. Results andDiscussion
2.1. General Aspects. Complex 1 was synthesized by heating
at 50◦C an acetonitrile/methanol solution of silver(I) chlo-
ride, TPTP and CMBZT in 1:2:1 molar ratio (reaction I):
AgCl +2TPTP + CMBZT
CH3CN/MeOH
−−−−−−−−→
50◦C

AgCl(CMBZT)(TPTP)2(MeOH)

(1)
(I)
Complexes 2–4 [10, 30, 31] were synthesized by heating,
under reﬂux, a toluene solution of silver(I) halides with
TPTP in the appropriate molar ratio. Finally, the water
solublecluster5waspreparedaccordingtomethodsreported
previously [32]. Complex 1 was characterized ﬁrst by
elemental analyses and spectroscopic methods. Crystals of
complexes 1–3 are stable in air but were kept in darkness.
Complexes 1–3 were soluble in MeCN, CHCl3,C H 2Cl2
DMSO, DMF and CH3OH, while complex 4 is slightly
soluble in DMSO. Complex 5 is highly soluble in water, in
DMSO and in DMF.
2.2. Vibrational Spectroscopy. The vibrational thioamide
bands I and II, appear at 1496 and 1305cm−1 in the IR
spectra of complex 1 and lie at lower wavenumbers com-
pared to the corresponding vibrational bands of the free
ligands CMBZT, observed at 1504 and 1313cm−1 [33].
Thioamide bands III-IV were observed at 1040–918cm−1
in the spectra of the free ligand C–P and appear at 1026
and 905cm−1, respectively, in the spectra of 1. The bands
at 1093cm−1 in the IR spectra of 1 and 2–4 are assigned
to the symmetric vibrations of the ν(C–P) bond [10].
Those at 515, 509cm−1 1, 515, 509cm−1 2, 516, 505cm−1 3
and 516, 505cm−1 4 are assigned to the antisymmetric
vibrations of the ν(C–P) bond [10]. The corresponding ν(C–
P) bands of the free tri-p-tolylphosphine ligand are found
at 1089cm−1 for the symmetric vibration and at 516cm−1,
505cm−1 for the anti-symmetric vibration. The bands at
169, 179, 125 and at 127cm−1 in the Far-IR spectra of
complexes 1–4 were assigned to the vibrations of the Ag–
X bonds (X = Cl, I), respectively, [10]. The vibration at
248cm−1 in the spectra of 1 is attributed to the Ag–S bonds
[34].
2.3. Crystal and Molecular Structure of {[AgCl(CMBZT)
(TPTP)2] ·(MeOH) (1) and Structural Properties of {[AgCl
(TPTP)3]·(0.5·H2O)} (2) and [AgI(TPTP)3] (3). We have
recently reported the crystal structure of the dehydrated
complex [AgCl(TPTP)3] at 293K [10]. The structure of
{[AgCl(TPTP)3]·(0.5·H2O)} (2), described here, has been
determined at 120K. The structure of [AgI(TPTP)3]( 3),
determined at 120K, is a new polymorph of the complex
reported previously at 293K and 140K [10, 30]. Strong Ag–
Ag interactions, due to quasiaromaticity calculated, were
found in the structure of complex 4 re-determined at 120K
(With Ag–Ag bond distance of 3.1182(3) ´ ˚ A) (Figure 3).
T h ec r y s t a ls t r u c t u r e so fc o m p l e x e s1-2 are shown in
Figures1and2,whileselectedbondlengthsandanglesfor1–
3aregiveninTable 1 incomparisonwiththosefoundin[10].
TwoPatomsfromtheTPTPligands,oneSfromCMBZT
and one Cl atom form the tetrahedral arrangement around
the Ag ion in complex 1. The two Ag–P bond lengths are
Ag1–P1 = 2.4357(18) ´ ˚ Aa n dA g 1 – P 2= 2.5013(16) ´ ˚ Aw h i c h
correspond closely with those found in [Ag(PPh3)(L)Br]2
(PPh3 = triphenylphosphine and L = 2 pyrimidine-2-thione)
where Ag(1)-P(1) = 2.4390(7) ´ ˚ A[ 34] and in [Ag2X2(l-S-
pySH)2(PPh3)2]( X= Cl, Br and l-S-pySH = pyridine-2-
thione) where the Ag–P bond distances are 2.435(1) ´ ˚ Aa n d
2.441(1) ´ ˚ A, respectively, [35].
The Ag–S bond distance in 1 (Ag1-S32 = 2.6486(16) ´ ˚ A)
is longer than the corresponding bond distances reported for
the terminal Ag-S bonds found in [Ag(PPh3)(L)Br]2 (PPh3=
triphnylphosphine and L = 2 pyrimidine-2-thione) (Ag(1)-
S(1) = 2.5548(9) ´ ˚ A[ 34]) and in [Ag2X2(μ-S-pySH)2(PPh3)2]
(X = Cl, Br and μ-S-pySH = pyridine-2-thione) (Ag-Sterminal
are 2.583(1) ´ ˚ A and 2.608(1) ´ ˚ A, resp., [35]). The Ag–S bond
distance in 1 is closer to the bond length of bridging
Ag-S bonds measured in [Ag2X2(μ-S-pySH)2(PPh3)2]( X
= Cl, Br and μ-S-pySH = pyridine-2-thione) (Ag-Sbridging
are 2.721(1) ´ ˚ A and 2.631(1) ´ ˚ A, resp., [35]). This might beBioinorganic Chemistry and Applications 3
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Figure 1: (a) ORTEP diagram of the crystal structure of complex
1. (b) Intramolecular interactions (N33···Cl4, S31···O1S and
O1S···Cl4) in 1.
due to intramolecular contact S31···O1S (i) = 3.240(6) ´ ˚ A
(Figure 1(b)) (the symmetry transformation used to gener-
ate the equivalent atoms for (i) = −x,−y,1−z).
The Ag1-Cl4 bond distance in 1 is 2.6736(13) ´ ˚ A and is
longer than the corresponding Ag-Cl bond distance found
in [Ag2Cl2(μ-S-pySH)2(PPh3)2]( p y S H= pyridine-2-thione)
(Ag-Cl = 2.530(1) ´ ˚ A[ 35]). This is due to the participation of
the Cl atom in two strong hydrogen bonding interactions,
one inter-molecular (N33···Cl4 = 3.083(4) ´ ˚ A)a n do n e
intramolecular (O1S···Cl4 = 3.147(5) ´ ˚ A) (Figure 1(b)).
The hydrogen bonding interactions which involve the O
atom of the methanol lead to the formation of a dimer
(Figure 1(b)).
The bond angles around the Ag atom show variations
from those in an ideal tetrahedron and range from P1-Ag1–
P2 = 129.05(5)◦ to P2-Ag1-Cl4 = 95.13(5)◦ (see Table 1).
Thereﬁnementoftheabsolutestructureof 2showedthat
it consists of a mixture of enantiomers with ratio 0.81: 0.19.
Signiﬁcantdiﬀerencesbetweenthebonddistancesandangles
of complex 2 at 120K and the anhydrous form at 293
were observed and the values are also given in Table 1 for
comparison. Although, the Ag–P bond lengths are shortened
by decreasing the temperature (Table 1), the Ag-Cl bond
distance remains unchanged (Table 1). This is attributed to
the formation of a strong hydrogen bonding interaction
involving the Cl atom in 2 (H1B[O1]···Cl1 = 2.42(10) ´ ˚ A,
O1-H1B···Cl1 = 150(18)◦)( Figure 2(b)), in contrast to the
case of the dehydrated complex [AgCl(TPTP)3], where no
such bonds are formed.
The crystal structure of complex 3 determined at 120K
(this work) is a new polymorphic form of the corresponding
structures determined at 140K and 293K [10] (120K:
monoclinic in space group C2/c with a = 22.7429(10) ´ ˚ A,
b = 11.0093(3) ´ ˚ A, c = 44.8281(18) ´ ˚ A, β = 102.9780(10)◦,
and at 140K. At 293K: triclinic in space group P-1 with
(140K) a = 11.0058(5) ´ ˚ A, b = 11.4509(5) ´ ˚ A, c = 22.9459(8) ´ ˚ A,
α = 99.461(3)◦, β = 91.648(3)◦, γ = 106.350(4)◦ [10]. The
general trend in complex 3 is the increasing of bond lengths;
by increasing of temperature, for example the average Ag–
P bond lengths in the various polymorphs are: at 120K
(new polymorph) 2.511 ´ ˚ A, at 140K (old polymorph) 2.537 ´ ˚ A
and at 293K (old polymorph) 2.547 ´ ˚ A. More important
changes were observed in the bond angles between the three
polymorphs (see Table 1).
Strong Ag–Ag interactions exist in the structure of
complex 4, consisted of four silver(I) ions bridged by μ3-
iodide ions, forming a prismatic core (Figure 3)a n da r e
described here for the ﬁrst time (both Ag–Ag = 3.1182(3) ˚ A),
with the Ag–Ag bond distances being shorter than the sum
of their van der Waals radii (4.20–4.74 ˚ A[ 36]) indicating a
d10-d10 interaction.Bioinorganic Chemistry and Applications 5
Ag1 Cl1
P1
P2
P3
O1
(a)
Ag1
O1
Cl1
Cl1
O1
Ag1
(b)
Figure 2: (a) ORTEP diagram of the crystal structure of complex 2. (b) Packing diagram and hydrogen bonding interactions (Cl1···O1)
in 2.
2.4. Computational Studies. A computational study utilizing
the method of nucleus-independent chemical shifts (NICS)
was employed for 4 in order to verify the Ag–Ag bonding
interactions. Theoretical as well as experimental evidence of
aromaticity in all-metal systems [20–29, 37–39] has attracted
immense attention. This type of molecule contains either
an aromatic cycle completely composed of metal atoms [40]
or ligand-stabilized aromatic clusters with the ligands being
either terminal or bridging adjacent metal atoms [41, 42].
Inaddition,aromaticclustersinvolvingd-orbitalsinpseudo-
octahedral and in tetrahedral three-dimensional metal cages
were comprehensively studied by the use of DFT methods
[43].Inthiswork,weextendourstudyofaromaticityapplied
to laboratory data [10, 29] by means of magnetic criteria,
using the method of nucleus-independent chemical shifts
(NICS)proposedbyCorminboeufetal.in1996[21]toassess
the aromatic character of cyclic structures. The calculated
NICS indexes were obtained by calculating the negative
isotropic value of the absolute NMR shieldings at the Ag4I4
cluster centre (P1) and at distances ranging from −3.0t o
+3.0 ˚ Ainallthreedimensionswithastepof1.0 ˚ Aresultingin
19ghostatomsplusoneghostatomlocatedatthecentre(P2)
of the plane delimited by the three nearest Ag atoms (NICS-
3Ag) (Figure 3(a)). Signiﬁcantly negative (i.e., magnetically
shielded) NICS values (in ppm) indicate aromaticity while
small (close to zero) NICS values represent non-aromaticity.
The variation of NMR shieldings along the three C2 axes
with the distance from the cluster barycentre is illustrated in
Figure 3(b). The inner region is shielded up to −11.4ppm
at a distance of ±1 ˚ Aw h e r e a sN I C S ( 0 )i s– 7 . 1 p p m .T h e
corresponding value for benzene, at the same level of theory,
is −9.0ppm. The results are indicative of diatropic regions
attributed to the electron delocalization of d or (d-p) π-type
orbital electron density between the four Ag and I atoms
[10, 25, 26, 29, 44] which also justiﬁes the equalization of
theAg–Ibondsinthehomometalliccluster.Thesymmetrical
ﬂuctuations of the NICS values as well as the similar ones
obtained along X and Y axes are explained by the S4
symmetrymotifadopted bytheAg4I4 fragment.Lower NICS
values are found along the Z axis due to the weak bonding
interaction between the two Ag atoms sited at 3.539 ˚ Aa p a r t ;
this distance is closer to the twice the van der Waals radius
for silver (4.20–4.74 ˚ A[ 36]). NICS-3Ag value is −7.3ppm,
consistent with the above results. This quasi aromaticity
results in strong Ag–Ag interactions and in higher stability
of the Ag4I4 core.
2.5. Biological Tests
2.5.1. Cytotoxicity. Complexes 1–4 and the water sol-
uble silver(I) cluster of formula {[(Et3NH)+]2·[Ag6(μ3-
Hmna)4(μ3-mna)2]2−·(DMSO)2·(H2O)} (5)( H 2MNA = 2-
mercaptonicotinic acid, C6H5NO2S) [32], were tested for
their in vitro cytotoxic activity against leiomyosarcoma
cancercells(LMS)(mesenchymaltissue)fromtheWistarrat,
polycyclic aromatic hydrocarbons (PAH, benzo[a]pyrene)
carcinogenesis. The cell viability and the cell growth pro-
liferation activities were evaluated with Trypan Blue and
T h i a z o l y lB l u eT e t r a z o l i u mB r o m i d e( M T T )a s s a y s ,r e s p e c -
tively. The IC50 values for cell viability are: 8 ± 0.39μM( 1),
0.8 ± 0.08μM( 2), 1.5 ± 0.06μM( 3), 13.2 ± 0.42μM( 4)
and 4.5 ± 0.23μM( 5). Thus, the order of the complexes
activity towards cell viability is 2 > 3 > 5 > 1 > 4, indicating
that complex 2 is the strongest one. The IC50 values for
cell growth proliferation are: 13.7 ± 3.06μM( 1), 1.3 ±
0.2μM( 2), 2.9 ± 0.31μM( 3), 21.2 ± 1.93μM( 4) and 40.3
± 2.62μM( 5). The order of the inhibitory activity of the
c o m p l e x e si nc e l lg r o w t hp r o l i f e r a t i o ni s2 > 3 > 1 > 4
> 5. Thus, the chloride containing complex 2 showed the
strongest activity against LMS cells. The IC50 value for cell
viability determined for 2 is similar to the corresponding
value found for the de-hydrated complex (0.7μM) [10].
However, the IC50 value for cell viability determined for6 Bioinorganic Chemistry and Applications
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Figure 3: (a) The C2 axes in the Ag4I4 core of the cluster 4, along
whichNICSvalueshavebeencalculated.(b)PlotoftheNICSvalues
calculated along the three C2 axes.
3 varies signiﬁcantly (twofold) from the corresponding
value found for its polymorphic form (0.8μM) [10]. The
higher IC50 value in cell viability found for 4 (13.2μM)
compared with the corresponding ones for 1–3 (0.8–8μM)
might be attributed to the high stability of 4 due to the
quasiaromaticity detected (see above).
The activities of complexes 2, 3,a n d5, against cells
viability are comparable to that of cisplatin, with the
corresponding (IC50) value for cisplatin against LMS cells
being 4-5μM[ 12]. However, the inhibitory activities of
complexes 1–4, on the cells growth proliferation are higher
than that of cisplatin, with IC50 value against LMS cells being
25μM.
It is noteworthy to mention that none of the complexes
1–5showedanyactivityoncellgrowthproliferationofMRC-
5 cells (normal human fetal lung ﬁbroblast).
2.5.2. Flow Cytometry. A ﬂow cytometry assay was used to
quantifyapoptoticornecroticcellstreatedwithcompound1.
Treated and untreated LMS cells were stained with Annexin
V-FITC and Propidium Iodide (PI). Figure 4, shows the
dose-dependent cytotoxic response in LMS cells through
apoptosis when treated with 1. Compared to untreated LMS
cells which showed a total of 9.22% of background cell
death, the cells treated with complex 1 at 8μM showed
10.37% apoptosis (early apoptotic cells (Ann+/PI−)a n d
late apoptotic cells (Ann+/PI+)) and 1.20% necrosis. When
LMS cells were treated with 12μMo f1, the cell death was
increased to 29.37% apoptosis (early and late apoptotic cells)
and 3.84% necrosis. At higher than the IC50 concentration
of 1 (15μM), 62.38% of LMS cells were early and late
apoptotic cells and 7.05% were necrotic. Thus, 1 causes a
dose-dependent cytotoxic response in LMS cells through
apoptosis. Although, no direct comparison can be made due
to the diﬀerent cell lines used, the apoptosis of HeLa cells
induced by 33.75μM solution of organogold(III) complexes
containing the “pincer” iminophosphorane ligand (2-C6H4-
PPh2=NPh) of formula [Au{κ 2-C,N-C6H4(PPh2=N(C6H5)-
2}Cl2] is 23.3% [45], in contrast to the 62.38% of 1 against
LMS cells, which might indicate stronger interaction of 1
with DNA.
2.5.3. Anti-Inﬂammatory Activity. Apoptotic cell death
requires interaction of the complexes with DNA, which
results into antimicrobial activity and to the burn wound
recovery of the complexes [9]. Complexes 1–3 and 5 were
tested for their anti-inﬂammatory activity. Figure 5 shows
the changes of the burnt surface of animals after 21 days
treatmentwithsolvent (glyceryltrioctanoate) and complexes
1–3 and 5 in contrast to the burnt surface at 0 days, in
comparison with the corresponding value for the untreated
animals (control). The animals of the control group showed
7.38% decrease of the burnt surface, while the animals of
the solvent group showed 15.67% decrease of the burnt
surface. Furthermore, animals of the group treated with 1,
2 and 5, showed 51.33%, 39.32% and 26.76% decrease of the
burnt surface, respectively. Therefore, the order of the anti-
inﬂamatory activity caused by silver(I) complexes is 1 > 2 >
5> ···>3. Thus, the chloride containing complexes 1 and 2
werefoundtodecreasetheburntsurfacemosteﬀectively.The
mixed ligand Ag(I) with phosphine and the thione CMBZT,
complex 1, showed the strongest anti-burn activity which
might be due to the synergistic eﬀect of the chlorine and
thioamide ligands.
3. Conclusions
Silver(I) halide complex 1 was synthesized and characterized
by single crystal X-ray diﬀraction analysis. Complex 2 X-
ray crystal structure on the other hand, showed that it
deferred from the structure of complex [AgCl(TPTP)3][ 10]
containing a water molecule. The re-determination of the
the structure of [AgI(TPTP)3]( 3) determined at 120K is a
new polymorphic form of the complex reported previously
at 293K and 140K [10]. A computational study using
the method of nucleus-independent chemical shifts (NICS)
showed that the Ag4I4 core of complex 4 exhibits strongBioinorganic Chemistry and Applications 7
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Figure 4: Flow cytometry assay summary results for LMS cells, treated with various concentrations of 1 (8, 12, and 15μM) for 48 hours of
incubation, in comparison with the untreated cells (control).
quasiaromaticity, which at the inner region is shielded up
to −11.4ppm, resulting in the formation of strong Ag–Ag
bonds.
The results of testing complexes 1–5, for their in vitro
cytotoxic activity against leiomyosarcoma cancer cells (LMS)
(mesenchymal tissue) from the Wistar rat, polycyclic aro-
matic hydrocarbons (PAH, benzo[a]pyrene) carcinogenesis,
showed that the chloride containing complex 2 had the
strongest activity against LMS cells. The order of the
complexes activity towards cell viability is 2 > 3 > 5 > 1 >
4, while the order of the inhibitory activity of the complexes
in cell growth proliferation is 2 > 3 > 1 > 4 > 5.T h eI C 50
value for cell viability determined for 2 is similar to the
corresponding value found for the de-hydrated complex
[10]. However, the IC50 value for cell viability determined
for 3( crystallized in monoclinic, C2/c space group), varies
signiﬁcantly (twofold) from the corresponding value found
for its polymorphic form (crystallized in triclinic, P-1 space
group) [10]. The low biological activity of 4 might be
attributed to its high stability due to the quasiaromaticity
detected. The type of cell death in the case of complex 1 was
also evaluated by use of a ﬂow cytometric assay.
The results showed that 1 causes a dose-dependent
cytotoxicresponseinLMScellsthroughapoptosis.Apoptotic8 Bioinorganic Chemistry and Applications
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Figure 5: Change of the burnt surfaces after 21 days treatment with
thesolventandcomplexes1–3and5incontrasttotheburntsurface
at 0 days.
cell death requires interaction of the complexes with DNA,
whichresultsintotheirantimicrobialactivityandtotheburn
wound recovery [9].
The chloride containing complexes 1 and 2 were also
found to decrease the burnt surface most eﬀectively. The
order of the anti-inﬂamatory activity caused by silver(I)
complexes is 1 > 2 > 5 > ···> 3.T h em i x e dl i g a n dA g ( I )
with phosphine and the thione CMBZT, complex 1, showed
the strongest anti-inﬂammatory activity which might be due
tothesynergisticeﬀectofthechlorideandthioamideligands.
Among complexes 1–3 and 5,c o m p l e x2, which showed
the strongest activity against cells viability and the highest
inhibitory activity against cells proliferation, also found to
exhibit strong burn wood recovery activity.
4. Experimental
4.1. Materials and Instruments. All solvents used were of
reagent grade. Silver(I) chloride and Silver(I) iodide were
prepared by mixing aqueous solutions of AgNO3 with
the appropriate amount of NaCl and NaI (Merck or
Aldrich), respectively. The precipitates were ﬁltered oﬀ and
dried in darkness. Tri-p-tolyl-phosphine and 5-chloro-2-
mercaptobenzothiazole (Fluka, Aldrich) were used with no
further puriﬁcation. Melting points were measured in open
tubes with a Stuart Scientiﬁc apparatus and are uncorrected.
IR spectra in the region of 4000–370cm−1 were obtained
from KBr discs, while far-IR spectra in the region of 400–
30cm−1 were obtained from polyethylene discs, with a
Perkin-Elmer Spectrum GX FT-IR spectrophotometer.
4.2. Synthesis and Crystallization of {[AgCl(CMBZT)
(TPTP)2]·(MeOH)} (1), {[AgCl(TPTP)3]·(0.5·H2O)} (2),
[AgI(TPTP)3] (3) and {[AgI(TPTP)]4} (4). Complex 1
was synthesized as follows: A solution of 0.202g CMBZT
(0.5mmol) in 10 ml methanol was added to a suspension
of 0.072g AgCl (0.5mmol) and 0.304 g TPTP (1mmol)
in 10ml acetonitrile and the mixture was stirred for
1hourat50 ◦C. The clear solution was ﬁltered oﬀ and the
ﬁltrate was kept in darkness. After a few days a pale yellow
powder was precipitated. Crystals of complex 1 suitable
for X-ray crystallographic analysis were obtained from a
toluene/chloroform solution. Complexes 2–4 were prepared
by heading toluene solutions of the appropriate amounts of
silver(I) halides with TPTP under reﬂux for 3 hours. The
clear solutions were ﬁltered oﬀ and the ﬁltrates were kept
in darkness. Colorless crystals of complexes 2–4 suitable
for X-ray crystallographic analysis were grown from the
ﬁltrates.
1: Yield: 44%; m.p: 178–181◦C; {[C49H46P2AgCl2NS2]
·(CH3OH)} (MW = 985.7); elemental analysis:
found C = 60.75%, H = 5.21%, N = 1.39%, S =
6.87%; calcd: C = 60.92%, H = 5.11%, N = 1.42%,
S = 6.50%. MID-IR (cm−1) (KBr): 3013, 2915, 1496,
1305, 1093, 1026, 802, 658, 515, 509, Far-IR (cm−1)
(polyethylene): 248, 169.
2: Yield: 80%; m.p: 199–205◦C; {[C63H63P3AgCl]·(0.5
H2O)} (MW = 1065.4); elemental analysis: found C
= 70.55%, H = 6.24%; calcd: C = 70.43%, H = 6.09%.
MID-IR (cm−1) (KBr): 3013, 2911, 1093, 800, 516,
509, Far-IR (cm−1) (polyethylene): 179.
3: Yield: 83%; m.p: 145–152◦C; {C63H63P3AgI} (MW
= 1147.8); elemental analysis: found C = 65.30%, H
= 5.87%; calcd: C = 65.92%, H = 5.53%. MID-IR
(cm−1) (KBr): 3008, 2915, 1093, 802, 516, 505, Far-
IR (cm−1) (polyethylene): 125.
4: Yield: 56%; m.p: 278–283◦C; {C84H84P4Ag4I4}
(MW = 2156.5); elemental analysis: found C =
46.28%, H = 3.88%; calcd: C = 46.79%, H = 3.92%.
MID-IR (cm−1) (KBr): 3013, 2911, 1095, 802, 516,
505, Far-IR (cm−1) (polyethylene): 127.
4.3. X-Ray Structure Determination. X-ray diﬀraction data
from the crystals of 1 w e r ec o l l e c t e do naK U M AK M 4 C C D
four-circle diﬀractometer [46] with a CCD detector, using
graphite-monochromated MoKα radiation (λ = 0.71073˚ A)
at 293(2)K. Unit cell parameters were determined by a
least-squares ﬁt [47] .A l ld a t aw e r ec o r r e c t e df o rL o r e n t z -
polarization eﬀects and absorption [47, 48]. The structure
was solved by direct methods using SHELXS-97 [49]a n d
reﬁned by a full-matrix least-squares procedure on F2 with
SHELXL-97 [49]. All non-hydrogen atoms were reﬁned
anisotropically while hydrogen atoms were located at cal-
culated positions and reﬁned using a “riding model” with
isotropic displacement parameters based on the equivalent
isotropic displacement parameter (Ueq) of the parent atom.
X-ray diﬀraction data from the crystals of 2 and 3
were collected on a Bruker APEXII CCD diﬀractometer
and data from crystals of 4 were collected on a Bruker
CCD diﬀractometer, both at the window of a Bruker FR591
rotating anode (λ = 0.71073 ˚ A) at 120(2)K. The data
c o l l e c t i o n sw e r ed r i v e nb yC O L L E C T[ 50] and processed
by DENZO [51]. Absorption corrections were applied using
SADABS [52]. The structures of 2 and 3 were solved using
SHELXS-97 [49] while that of 4 was solved in SIR2004 [53]
and all three structures were reﬁned in SHELXL-97 [49]. All
non-hydrogen atoms were reﬁned anisotropically. In 2 there
isawatermoleculepresentinthestructureat50%occupancy
for which the hydrogen atom positions were located in the
electron density. The remaining hydrogen atoms of 2 and allBioinorganic Chemistry and Applications 9
Table 2: Crystal data and structure reﬁnement details for complexes 1–4.
1; 293K 2; 120K 3; 120K 4; 120K
Empirical formula C50H50AgCl2NOP2S2 C63H64AgClO0.5P3 C63H63AgIP3 C84H84Ag4I4P4
Fw 985.7 1065.4 1147.8 2156.5
Temperature (K) 293(2) 120(2) 120(2) 120(2)
Cryst. System Triclinic Orthorhombic Monoclinic Tetragonal
Space group P1 Pna21 C2/c I41/a
a, ˚ A 11.226(4) 20.2646(4) 22.7429(10) 24.0727(2)
b, ˚ A 13.659(5) 26.0074(5) 11.0093(3) 24.0727(2)
c, ˚ A 18.227(7) 10.5020(2) 44.8281(18) 13.8592(2)
α, deg 98.97(3) 90 90 90
β, deg 98.08(3) 90 102.9780(10) 90
γ, deg 113.97(4) 90 90 90
V, ˚ A3 2457.4(16) 5534.86(19) 10937.5(7) 8031.34(15)
Z 44 8 4
ρcalcd,gc m −3 1.332 1.279 1.394 1.783
μ,m m −1 0.7 0.5 1.1 2.6
R, wR2 [I > 2σ(I)], 0.0458, 0.1279 0.0598, 0.1073 0.0723, 0.2064 0.0299, 0.0773
those in 3 and 4 were reﬁned using a “riding model” in a
similar manner to those in structure 1. For structure 2 the
reﬁned absolute structure parameter was 0.19 (3), indicating
that the structure consists of a mixture of enantiomers with
ratio 0.81:0.19. Signiﬁcant crystal data are given in Table 2.
Supplementary data are available from CCDC, 12 Union
Road, Cambridge CB2 1EZ, UK, (e-mail: deposit@ccdc
.cam.ac.uk), on request, quoting the deposition numbers
CCDC 715884 (1), 717733 (2), 717734 (3) and 717735 (4),
respectively.
4.4. Computational Details. Calculations based on the
molecular geometry acquired via X-ray diﬀraction methods
were carried out with the Gaussian03W program package
[54]. Magnetic shielding tensors for a ghost atom placed at
diﬀerent interior and near exterior positions of the Ag4I4
cluster were computed using the gauge-independent atomic
orbital (GIAO) DFT method [55–57] within the B3LYP
level of theory. Nucleus independent chemical shift (NICS)
values were estimated with the B3LYP function using the Los
Alamos ECP plus double zeta (LANL2DZ) basis set for the
Ag atoms and the 6-311G(d,p) for all the others.
4.5. Biological Tests
4.5.1. Trypan Blue Assay. A trypan blue dye exclusion assay
was used to determine cell viability. A cell suspension
was prepared using brief trypsinization (250μL of trypsin-
incubation at 37◦C, 95% O2,5 %C O 2). An equal volume of
PBS was added and the suspension was mixed with 500μL
of 0.4% Trypan blue solution and left for 5 minutes at
room temperature. The stained (dead) cells and the total
cells per square of the cell chamber were counted using
Neubauer cytometer after 24 hours of incubation with
diﬀerent concentrations of complexes 1–4 and 5.
4.5.2. MTT Assay. Cell growth inhibition was analyzed using
the 3-(4,5-dimethylthiazol-2-yl)-2,5-diphenyltetrazolium
bromid (MTT) assay. LMS cells cultured on 96-well plates
were washed with PBS. A solution containing diﬀerent
concentrationsofcomplexes1–4and5wasthenadded.After
incubation for 24 hours, 50μlo fM T Tw a sa d d e di ne a c h
well from a stock solution (5mg/ml), and incubated for an
additional 4 hours. Blue formazans were eluted from cells by
adding 50μl of DMSO under gentle shaking and absorbance
was determined at 570nm (subtract background absorbance
measured at 690nm) using a microplate spectrophotometer
(Multiskan Spectrum, Therno Fisher Scientific, Waltham,
USA).
4.5.3. Flow Cytometry. LMS cells were seeded onto six-well
plates at a density of 6 × 104 cells per well and incubated
for 24 hours before the experiment. Cells were washed with
PBS, treated with media containing various concentrations
of 1 in DMSO (8, 12 and 15μM) and incubated for 48 hours.
Supernatants and cells collected were centrifuged and cell
pellets were suspended in calcium buﬀer 1× at a rate 105
cells/100μl. Cells were stained with Annexin (BD 556420)
and Propidium Iodide (Sigma P4864) in a dark room for 15
minutes. DNA content was determined on a FACScan ﬂow
cytometer (Partec ML, Partec GmbH, Germany). Percentage
ofapoptotic,necroticanddecompensatecellswerecalculated
over all viable cells (100%).
4.6. Anti-Inﬂammatory Activity
4.6.1. Substances Preparation. The complexes 1–3and5 were
dissolved in Glyceryl trioctanoate minimum 99% (from
Sigma-T9126), to a concentration of 2 × 10−4 M and the
s o l u t i o n sw e r ek e p ta t4 ◦C during the experiment.10 Bioinorganic Chemistry and Applications
4.6.2. Animal Preparation. All animals were anaesthetized
with 1ml of anaesthetic cocktail (50mgr/10 ml Midazolame,
50mgr/10ml Ketamine, Sodium Chloride 0.9% at a ratio
1.5/0.5/3) given into the peritoneal. After anaesthetization
and 5cm2 of skin removal, all animals were burnt for
5 seconds at a speciﬁc area by candescent steely stamp.
This stamp had been put over a Bunsen lamp for at least
10 minutes. The average of the total burnt surface area
represented 1.6% of the total body surface. The burnt area
was cleaned by a sterilized dry paper and impressed on a
clear paper by a permanent marker, in order to estimate the
burnt surface area. A planimeter was also used to determine
the burnt surface.
After burning, the animals were separated into 6 groups
(6 animals in each group). The ﬁrst group was the control
group (CG) in which the 6 animals had no treatment. The
second group was the solvent group (SG), in which all the
animals were treated only with the glyceryl trioctanoate as
solvent. The other 4 groups were the experiment groups
(EG1-EG4),inwhichanimalsweretreatedwiththesolutions
of the complexes in glyceryl trioctanoate. The treatment was
performed by inducted 1.75ml/day solutions over the burnt
area. The treatment was continued for 20 days for all groups.
At the 21st day the ﬁnal burnt surface areas were estimated.
4.6.3. Animals and Its Treatment. Female Wistar rats (36),
aged 5 months and weighting almost 190gr were reared
in the laboratory in community cages at controlled room
temperature (20 ± 2◦C), with controlled lighting (12h light/
12h dark). Standard Wistar rat diet and water ad libitum
were used in all the experiments.
Experiments on animals were handled with human
care in accordance with the National Institutes of Health
guidelines and the European Union directive for the care and
the use of laboratory animals (Greek presidential decree No.
160 1991).
Acknowledgment
Thisworkwascarriedoutinpartialfulﬁlmentoftherequire-
ments for the graduate studies of L. K. under the supervision
of S. K. H.
References
[1] B. Krebs and G. Hengel, “Transition-metal thiolates: from
molecular fragments of sulﬁdic solids to models for active
centers in biomolecules,” Angewandte Chemie International
Edition, vol. 30, no. 7, pp. 769–788, 1991.
[2] P. G. Blower and J. R. Dilworth, “Thiolato-complexes of the
transitionmetals,” Coordination Chemical Reviews, vol. 76, pp.
121–185, 1987.
[3] E. S. Raper, “Complexes of heterocyclic thione donors,”
Journal of Coordination Chemistry, vol. 61, pp. 115–184, 1985.
[4] E.S.Raper,“Coppercomplexesofheterocyclicthioamidesand
related ligands,” Coordination Chemical Reviews, vol. 129, no.
1-2, pp. 91–156, 1994.
[5] E. S. Raper, “Complexes of heterocyclic thionates—part 1:
complexes of monodentate and chelating ligands,” Coordina-
tion Chemical Reviews, vol. 153, pp. 199–255, 1996.
[ 6 ] J .E .F .R a y n o l d s ,E d . ,Martidale the Extra Pharmacopoeia,T h e
Pharmaceutical Press, London, UK, 28th edition, 1982.
[7] M. Wruble, “Colloidal silver sulfonamides,” J o u r n a lo ft h e
American Pharmacists Association, vol. 32, no. 11, pp. 80–82,
1943.
[8] H. S. Rosenkranz and S. Rosenkranz, “Silver sulfadiazine:
interactionwithisolateddeoxyribonucleicacid,”Antimicrobial
Agents and Chemotherapy, vol. 2, no. 5, pp. 373–379, 1972.
[9] C. L. Fox Jr. and S. M. Modak, “Mechanism of silver
sulfadiazine action on burn wound infections,” Antimicrobial
Agents and Chemotherapy, vol. 5, no. 6, pp. 582–588, 1974.
[10] S. Zartilas, S. K. Hadjikakou, N. Hadjiliadis, et al., “Tetrameric
1:1 and monomeric 1:3 complexes of silver(I) halides with
tri(p-tolyl)-phosphine: a structural and biological study,”
Inorganica Chimica Acta, vol. 362, no. 3, pp. 1003–1010, 2009.
[11] P. C. Zachariadis, S. K. Hadjikakou, N. Hadjiliadis, et al.,
“Synthesis,characterizationandinvitrostudyofthecytostatic
and antiviral activity of new polymeric silver(I) complexes
with Ribbon structures derived from the conjugated hetero-
cyclic thioamide 2-mercapto-3,4,5,6-tetra-hydropyrimidine,”
European Journal of Inorganic Chemistry, vol. 2004, no. 7, pp.
1420–1426, 2004.
[12] S. K. Hadjikakou, I. I. Ozturk, M. N. Xanthopoulou, et al.,
“Synthesis, structural characterization and biological study
of new organotin(IV), silver(I) and antimony(III) complexes
with thioamides,” Journal of Inorganic Biochemistry, vol. 102,
no. 5-6, pp. 1007–1015, 2008.
[13] J. J. Roberts and J. M. Pascoe, “Cross-linking of comple-
mentary strands of DNA in mammalian cells by antitumour
platinum compounds,” Nature, vol. 235, pp. 282–284, 1972.
[14] M. N. Xanthopoulou, S. K. Hadjikakou, N. Hadjiliadis, et
al., “Biological studies of new organotin(IV) complexes of
thioamide ligands,” European Journal of Medicinal Chemistry,
vol. 43, pp. 327–127, 2008.
[15] K. Nomiya, Y. Kondoh, H. Nagano, and M. Oda, “Character-
ization by electrospray ionization (ESI) mass spectrometry of
an oligomeric, anionic thiomalato-silver(I) complex showing
biological activity,” Journal of The Chemical Society, Chemical
Communications, pp. 1679–1680, 1995.
[16] K.Nomiya,S.Takahashi,andR.Noguchi,“Synthesisandcrys-
tal structure of a hexanuclear silver(I) cluster [Ag(Hmna)]6 ·
4H2o(H2mna = 2-mercaptonicotinic acid)and a supramolec-
ular gold(I) complex H[Au(Hmna)2] in the solid state, and
their antimicrobial activities,” Journal of the Chemical Society:
Dalton Transactions, pp. 2091–2097, 2000.
[17] P. G. Blower and J. R. Dilworth, “Thiolato-complexes of the
transition metals,” Coordination Chemical Reviews, vol. 76, pp.
121–185, 1987.
[18] J.-M. Lehn, Supramolecular Chemistry Concepts and Perspec-
tives, Wiley-VCH, Weinheim, Germany, 1995.
[19] M. Hong, W. Su, R. Cao, M. Fujita, and J. Lu, “Assembly
of silver(I) polymers with helical and lamellar structures,”
EuropeanJournalofChemistry,vol.6,no.3,pp.427–431,2000.
[20] P. V. R. Schleyer, C. Maerker, A. Dransfeld, H. Jiao, and N. J.
Hommes,“Nucleus-independentchemicalshifts:asimpleand
eﬃcient aromaticity probe,” Journal of the American Chemical
Society, vol. 118, no. 26, pp. 6317–6318, 1996.
[21] C.Corminboeuf,C.S.Wannere,D.Roy,R.B.King,andP.V.R.
Schleyer, “Octahedral and tetrahedral coinage metal clusters:
is three-dimensional d-orbital aromaticity viable?” Inorganic
Chemistry, vol. 45, no. 1, pp. 214–219, 2006.Bioinorganic Chemistry and Applications 11
[22] C. S. Wannere, C. Corminboeuf, Z.-X. Wang, M. D. Wodrich,
R. Bruce King, and P. V. R. Schleyer, “Evidence for d orbital
aromaticity in square planar coinage metal clusters,” Journal of
theAmericanChemicalSociety,vol.127,no.15,pp.5701–5705,
2005.
[23] A. C. Tsipis and C. A. Tsipis, “Ligand-stabilized aromatic
three-membered gold rings and their sandwichlike com-
plexes,” Journal of the American Chemical Society, vol. 127, no.
30, pp. 10623–10638, 2005.
[24] C. A. Tsipis, E. E. Karagiannis, P. F. Kladou, and A. C.
Tsipis, “Aromatic gold and silver ‘rings’: hydrosilver(I) and
hydrogold(I) analogues of aromatic hydrocarbons,” Journal of
the American Chemical Society, vol. 126, no. 40, pp. 12916–
12929, 2004.
[25] A. C. Tsipis and C. A. Tsipis, “Hydrometal analogues of
aromatichydrocarbons:anewclassofcyclichydrocoppers(I),”
Journal of the American Chemical Society, vol. 125, no. 5, pp.
1136–1137, 2003.
[26] C. A. Tsipis, “DFT study of “all-metal” aromatic compounds,”
Coordination Chemical Reviews, vol. 249, no. 24, pp. 2740–
2762, 2005.
[27] J. Li, C.-W. Liu, and J.-X. Lu, “Theoretical studies of (d-p)p
bonding, electronic spectra, and reactivities in homo- and
heterometallie clusters: [Mo3−nWnX4(H2O)9]
4+(X = O, S, Se,
Te; n = 0 − 3),” Journal of Cluster Science, vol. 7, no. 3, pp.
469–500, 1996.
[28] Z. Chen, “Multicentered bonding and quasi-aromaticity in
metal-chalcogenide cluster chemistry,” Journal of Cluster Sci-
ence, vol. 6, no. 3, pp. 357–377, 1995.
[29] S. Zartilas, N. Kourkoumelis, S. K. Hadjikakou, et al., “A new
silver(I) aggregate having an octagonal Ag4S4 Core Where
μ3-S bonding interactions lead to a nanotube assembly that
exhibits quasiaromaticity,” Butler European Journal Inorganic
Chemistry, vol. 2007, no. 9, pp. 1219–1224, 2007.
[30] R. Meijboom, “Iodotris(tri-p-tolylphosphine)silver(I),” Acta
Crystallographica, vol. E63, pp. m78–m79, 2007.
[31] R. Meijboom, A. Muller, and A. Roodt, “Tetra-μ3-iodo-
tetrakis[(tri-p-tolylphosphine-κP)-silver(I),” Acta Crystallo-
graphica, vol. E62, pp. m2162–m2164, 2006.
[32] P.C.Zachariadis,S.K.Hadjikakou,N.Hadjiliadis,etal.,“Syn-
thesis, study and structural characterization of a new water
soluble hexanuclear silver(I) cluster with the 2-mercapto-
nicotinic acid with possible antiviral activity,” Inorganica
Chimica Acta, vol. 343, pp. 361–365, 2003.
[33] M. N. Xanthopoulou, S. K. Hadjikakou, N. Hadjiliadis, et
al., “Synthesis, structural characterization and in vitro cyto-
toxicity of organotin(IV) derivatives of heterocyclic thioam-
ides, 2-mercaptobenzothiazole, 5-chloro-2-mercaptobenzot-
hiazole, 3-methyl-2-mercaptobenzothiazole and 2-mercapto-
nicotinic acid,” Journal of Inorganic Biochemistry, vol. 96, no.
2-3, pp. 425–434, 2003.
[34] P. J. Cox, P. Aslanidis, P. Karagiannidis, and S. K. Had-
jikakou, “Silver(I) complexes with heterocyclic thiones and
tertiary phosphines as ligands—part 4: dinuclear complexes
of silver(I) bromide: The crystal structure of bis[bromo-(pyr-
imidine-2-thione)(triphenylphosphine)silver(I)],” Inorganica
Chimica Acta, vol. 310, no. 2, pp. 268–272, 2000.
[35] T. S. Lobana, R. Sharma, and R. J. Butcher, “Pyridine-2-
thione (pySH) derivatives of silver(I): synthesis and crys-
tal structures of dinuclear [Ag2Cl2(μ-S-pySH)2(PPh3)2]and
[Ag2Br2(μ-S-pySH)2(PPh3)2]complexes,” Polyhedron, vol. 27,
no. 5, pp. 1375–1380, 2008.
[36] S. S. Batsanov, “Van der waals radii of elements,” Inorganic
Materials, vol. 37, no. 9, pp. 871–885, 2001, translated from
Neorganicheskie Materialy, vol. 37, pp. 1031-1046, 2001.
[37] X. Li, A. E. Kuznetsov, H. Zhang, A. I. Boldyrev, and L. Wang,
“Observation of all-metal aromatic molecules,” Science, vol.
291, no. 5505, pp. 859–861, 2001.
[38] X. Huang, H. J. Zhai, B. Kiran, and L. S. Wang, “Observation
of d-orbital aromaticity,” Angewandte Chemie International
Edition, vol. 44, no. 44, pp. 7251–7254, 2005.
[ 3 9 ]S .E r h a r d t ,G .F r e n k i n g ,Z .C h e n ,a n dP .V .R .S c h l e y e r ,
“Aromatic boron wheels with more than one carbon atom
in the center: C2B8,3 B
3+
9 , and C5B
+
11,” Angewandte Chemie
International Edition, vol. 44, no. 7, pp. 1078–1082, 2005.
[40] S. Wannere, C. Corminboeuf, Z. X. Wang, M. D. Wodrich,
R. B. King, and P. V. R. Schleyer, “Evidence for d orbital
aromaticity in square planar coinage metal clusters,” Journal
of the American Chemical Society, vol. 127, no. 15, pp. 5701–
5705, 2005.
[41] E. Janssens, S. Neukemans, F. Vanhoutte, et al., “Ionization
potentials and structures of small indium monoxide clusters,”
Journal of Chemical Physics, vol. 118, pp. 5862–5871, 2003.
[42] R. B. King, “Chemical bonding topology of ternary transition
metal-centered bismuth cluster halides: from molecules to
metals,” Inorganic Chemistry, vol. 42, no. 26, pp. 8755–8761,
2003.
[43] C.Corminboeuf,C.S.Wannere,D.Roy,R.B.King,andP.V.R.
Schleyer, “Octahedral and tetrahedral coinage metal clusters:
is three-dimensional d-orbital aromaticity viable?” Inorganic
Chemistry, vol. 45, no. 1, pp. 214–219, 2006.
[ 4 4 ]Z .C h e na n dR .B .K i n g ,“ S p h e r i c a la r o m a t i c i t y :r e c e n tw o r k
on fullerenes, polyhedral boranes, and related structures,”
Chemical Reviews, vol. 105, no. 10, pp. 3613–3642, 2005.
[45] N. Shaik, A. Mart´ ınez, I. Augustin, et al., “Synthesis of
apoptosis-inducing iminophosphorane organogold(III) com-
plexes and study of their interactions with biomolecular
targets,” Inorganic Chemistry, vol. 48, no. 4, pp. 1577–1587,
2009.
[46] KUMA KM-4CCD User Manual, KUMA Diﬀraction, Wro-
claw, Poland, 1999.
[47] CRYSALIS, “Program for Reduction of the Data from KUMA
CCD Diﬀractometer,” KUMA Diﬀraction, Wroclaw, Poland,
1999.
[48] R. H. Blessing, “DREADD—data reduction and error analysis
for single-crystal diﬀractometer data,” Journal of Applied
Crystallography, vol. 22, pp. 396–397, 1989.
[49] G. M. Sheldrick, “A short history of SHELX,” Acta Crystallog-
raphy A, vol. 64, pp. 112–122, 2008.
[50] R. W. W. Hooft, COLLECT Data Collection Software,N o n i u s
B. V., Delft, The Netherlands, 1998.
[51] Z. Otwinowski and W. Minor, “Processing of X-ray diﬀraction
data collected in oscillation mode,” in Methods in Enzymology,
C. W. Carter Jr. and R. M. Sweet, Eds., vol. 276 of Macromolec-
ular Crystallography A, pp. 307–326, Academic Press, New
York, NY, USA, 1997.
[52] G. M. Sheldrick, SADABS, Bruker AXS, Madison, Wis, USA,
2007.
[53] M. C. Burla, R. Caliandro, M. Camalli, et al., “SIR2004:
an improved tool for crystal structure determination and
reﬁnement,” Journal of Applied Crystallography, vol. 38, pp.
381–388, 2005.
[54] M. J. Frisch, G. W. Trucks, H. B. Schlegel, et al., “Gaussian 03,
Revision C.02,” Gaussian, Wallingford, Conn, USA, 2004.12 Bioinorganic Chemistry and Applications
[55] R. M. Weeny, “Perturbation theory for the fock-dirac density
matrix,” Physical Review, vol. 126, no. 3, pp. 1028–1034, 1962.
[56] J. L. Dodds, R. McWeeny, and A. Sadlej, “Open-shell states in
perturbation-dependent non-orthogonal basis sets,” Journal
Molecular Physics, vol. 41, no. 6, pp. 1419–1430, 1980.
[57] R. Ditchﬁeld, “Self-consistent perturbation theory of
diamagnetism—I: a gauge-invariant LCAO method for
N.M.R. chemical shifts,” Molecular Physics,v o l .2 7 ,n o .4 ,p p .
789–807, 1974.